ADAMTS1 and cancer: As shown in Fig. 3A, blocking of ADAMTS1 with the corresponding antibodies greatly impaired 199C's cancer invasion promotion function on both MDA-MB-468 and MDA-MB-231 cells in an ADAMTS1 Ab dose-dependent manner (Fig. 3A).